AudioCure Pharma’s AC102 receives EMA orphan drug designation for the treatment of sudden sensorineural hearing loss (SSNHL) January 29, 2019https://www.biospace.com/article/releases/audiocure-pharma-s-ac102-receives-ema-orphan-drug-designation-for-the-treatment-of-sudden-sensorineural-hearing-loss-ssnhl-/